Incidence of cancer and antidepressant medication: Record linkage study

International Journal of Cancer

Volumn 126, Issue 1, 2010, Pages 285-296

  Haukka, Jari ^a,b   Sankila, Risto ^c   Klaukka, Timo ^d   Lonnqvist, Jouko ^b   Niskanen, Leo ^e   Tanskanen, Antti ^b   Wahlbeck, Kristian ^b   Tiihonen, Jari ^e  

^a Data Analysis and Interpretation Group   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c FINNISH CANCER REGISTRY   (Finland)

^d SOCIAL INSURANCE INSTITUTION   (Finland)

^e UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Antidepressant; Cancer; Pharmacoepidemiology

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; BRAIN CANCER; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; COLON CANCER; CONTROLLED STUDY; DEPRESSION; DRUG USE; FEMALE; FINLAND; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PRESCRIPTION; PRIORITY JOURNAL; PROSTATE CANCER; SEROTONIN UPTAKE; SEX RATIO;

ADULT; ANTIDEPRESSIVE AGENTS; CASE-CONTROL STUDIES; FEMALE; FINLAND; HUMANS; INCIDENCE; MALE; MEDICAL RECORD LINKAGE; MIDDLE AGED; NEOPLASMS;

EID: 73449140485     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24537     Document Type: Article

References (28)

1. National Agency for Medicines - Drug Consumption Statistics. Available from: http://www.nam.fi/medicines/drug-consumption. Last accessed August 22, 2008.
2. Reseland S, Bray I, Gunnell D. Relationship between antidepressant sales and secular trends in suicide rates in the Nordic countries. Br J Psychiatr 2006;188: 354-8.
3. Sternbach H. Are antidepressants carcinogenic? A review of preclinical and clinical studies. J Clin Psychiatr 2003;64: 1153-62.
4. Dalton SO, Johansen C, Mellemkjaer L, Sorensen HT II, McLaughlin JK, Olsen J, Olsen JH. Antidepressant medications and risk for cancer. Epidemiology 2000;11: 171-6.
5. Chien C, Li C, Heckbert S, Malone K, Boudreau D, Daling J. Antidepressant use and breast cancer risk. Breast Cancer Res Treat 2006;95:131-40.
6. Coogan PF, Palmer JR, Strom BL, Rosenberg L. Use of selective serotonin reuptake inhibitors and the risk of breast cancer. Am J Epidemiol 2005;162:835-8.
7. Coogan PF. Review of the epidemiological literature on antidepressant use and breast cancer risk. Expert Rev Neurotherap 2006;6: 1363-74.
8. Haque R, Enger SM, Chen W, Petitti DB. Breast cancer risk in a large cohort of female antidepressant medication users. Cancer Lett 2005;221:61-5.
9. Fulton-Kehoe D, Rossing MA, Rutter C, Mandelson MT, Weiss NS. Use of antidepressant medications in relation to the incidence of breast cancer. Br J Cancer 2006;94:1071-8.
10. Moorman PG, Berchuck A, Calingaert B, Halabi S, Schildkraut JM. Antidepressant medication use [corrected] and risk of ovarian cancer. Obstet Gynecol 2005;105: 725-30.
11. Tamim HM, Mahmud S, Hanley JA, Boivin J, Stang MR, Collet J. Antidepressants and risk of prostate cancer: a nested case-control study. Prostate Cancer Prostatic Dis 2008;11: 53-60.
12. Bahl S, Cotterchio M, Kreiger N, Klar N. Antidepressant medication use and non-Hodgkin's lymphoma risk: no association. Am J Epidemiol 2004;160:566-75.
13. Wang PS, Walker AM, Tsuang MT, Orav EJ, Levin R, Avorn J. Antidepressant use and the risk of breast cancer: a non-association. J Clin Epidemiol 2001;54: 728-34.
14. González-Pérez A, García Rodríguez LA. Breast cancer risk among users of antidepressant medications. Epidemiology (Cambridge, Mass) 2005;16:101-5.
15. Xu W, Tamim H, Shapiro S, Stang MR, Collet J. Use of antidepressants and risk of colorectal cancer: a nested case-control study. Lancet Oncol 2006;7:301-8.
16. Gil-Ad I, Zolokov A, Lomnitski L, Taler M, Bar M, Luria D, Ram E, Weizman A. Evaluation of the potential anti-cancer activity of the antidepressant sertraline in human colon cancer cell lines and in colorectal cancer-xenografted mice. Int J Oncol 2008;33:277-86.
17. WHO Collaborating Centre for Drug Statistics Methodology. Available from: http://www.whocc.no/ (last accessed August 11, 2008).
18. Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol 1994;33:365-9.
19. McCullagh P, Nelder J. Generalized linear models, 2nd edn. London: Chapman and Hall, 1994.
20. Goldacre MJ, Wotton CJ, Yeates D, Seagroatt V, Flint J. Cancer in people with depression or anxiety: record-linkage study. Soc Psychiatr Psychiatr Epidemiol 2007;42: 683-9.
21. Dalton SO, Mellemkjaer L, Olsen JH, Mortensen PB, Johansen C. Depression and cancer risk: a register-based study of patients hospitalized with affective disorders. Denmark, 1969-1993. Am J Epidemiol 2002;155:1088-95.
22. Serafeim A, Holder MJ, Grafton G, Chamba A, Drayson MT, Luong QT, Bunce CM, Gregory CD, Barnes NM, Gordon J. Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells. Blood 2003;101:3212-19.
23. Yue C, Liu Y. Fluoxetine increases extracellular levels of 3-methoxy-4-hydroxyphenylglycol in cultured COLO320 DM cells. Cell Biochem Func 2005;23: 109-14.
24. Bianchi MT. Non-serotonin anti-depressant actions: direct ion channel modulation by SSRIs and the concept of single agent poly-pharmacy. Medical Hypoth 2008;70(5): 951-6.
25. Harvey PW, Everett DJ, Springall CJ. Adverse effects of prolactin in rodents and humans: breast and prostate cancer. J Psychopharmacol 2008;22 (2 Suppl): 20-7.
26. Castaneda R, Sussman N, Westreich L, Levy R, O'Malley M. A review of the effects of moderate alcohol intake on the treatment of anxiety and mood disorders. J Clin Psychiatr 1996;57:207-12.
27. Cuijpers P, Schoevers RA. Increased mortality in depressive disorders: a review. Curr Psychiatr Rep 2004;6:430-7.
28. Jané-Llopis E, Matytsina I. Mental health and alcohol, drugs and tobacco: a review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs. Drug Alcohol Rev 2006; 25:515-36.